127 related articles for article (PubMed ID: 14767278)
1. Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension.
Naya Y; Slaton JW; Troncoso P; Okihara K; Babaian RJ
J Urol; 2004 Mar; 171(3):1093-7. PubMed ID: 14767278
[TBL] [Abstract][Full Text] [Related]
2. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
Tsuzuki T; Hernandez DJ; Aydin H; Trock B; Walsh PC; Epstein JI
J Urol; 2005 Feb; 173(2):450-3. PubMed ID: 15643200
[TBL] [Abstract][Full Text] [Related]
3. Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater.
Nakanishi H; Troncoso P; Babaian RJ
J Urol; 2008 Dec; 180(6):2441-5; discussion 2445-6. PubMed ID: 18930495
[TBL] [Abstract][Full Text] [Related]
4. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
[TBL] [Abstract][Full Text] [Related]
5. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
Elliott SP; Shinohara K; Logan SL; Carroll PR
J Urol; 2002 Jul; 168(1):105-9. PubMed ID: 12050501
[TBL] [Abstract][Full Text] [Related]
6. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
[TBL] [Abstract][Full Text] [Related]
7. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
Ochiai A; Troncoso P; Chen ME; Lloreta J; Babaian RJ
J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy.
Numao N; Kawakami S; Yonese J; Koga F; Saito K; Fujii Y; Ishikawa Y; Fukui I; Kihara K
Int J Urol; 2008 Dec; 15(12):1061-6. PubMed ID: 19120514
[TBL] [Abstract][Full Text] [Related]
9. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
[TBL] [Abstract][Full Text] [Related]
12. Location of a positive biopsy as a predictor of surgical margin status and extraprostatic disease in radical prostatectomy.
Touma NJ; Chin JL; Bella T; Sener A; Izawa JI
BJU Int; 2006 Feb; 97(2):259-62. PubMed ID: 16430624
[TBL] [Abstract][Full Text] [Related]
13. Intra-operative prostate examination: predictive value and effect on margin status.
Rapp DE; Orvieto MA; Lucioni A; Gong EM; Shalhav AL; Brendler CB
BJU Int; 2005 Nov; 96(7):1005-8. PubMed ID: 16225517
[TBL] [Abstract][Full Text] [Related]
14. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
15. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.
San Francisco IF; Regan MM; Olumi AF; DeWolf WC
J Urol; 2004 Apr; 171(4):1492-9. PubMed ID: 15017206
[TBL] [Abstract][Full Text] [Related]
16. Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance.
Ochiai A; Trpkov K; Yilmaz A; Donnelly B; Babaian RJ
J Urol; 2007 Mar; 177(3):907-10. PubMed ID: 17296373
[TBL] [Abstract][Full Text] [Related]
17. Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?
Hernandez DJ; Epstein JI; Trock BJ; Tsuzuki T; Carter HB; Walsh PC
J Urol; 2005 Feb; 173(2):446-9. PubMed ID: 15643199
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer volume at biopsy predicts clinically significant upgrading.
Dong F; Jones JS; Stephenson AJ; Magi-Galluzzi C; Reuther AM; Klein EA
J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180
[TBL] [Abstract][Full Text] [Related]
19. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
Loeb S; Roehl KA; Thaxton CS; Catalona WJ
Urology; 2008 Jul; 72(1):143-7. PubMed ID: 18436287
[TBL] [Abstract][Full Text] [Related]
20. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
